"The Quiet Hours" is a 78-minute contained psychological thriller, completed in 2025, in which a night-shift hospital cleaner becomes convinced that a patient in a coma is communicating with her through the ward's intercom system. Shot on a reported micro-budget in a single decommissioned hospital location with a cast of four, it is a debut feature from a director whose prior work is two festival-selected shorts. Materials submitted for this read are a synopsis, poster, three stills and a director bio — the finished film was not provided, so this assessment covers concept, visual identity and market position rather than pacing, performance or sound design.
The intercom-as-conduit device is a genuinely efficient horror engine: it justifies a single location, requires no creature or effects budget, and gives every scene a built-in source of dread. This is the kind of premise that reads as deliberate rather than budget-constrained.
One location, four cast, no VFX-dependent set pieces. For the tier of buyer that acquires contained genre features, this profile is a genuine advantage, not a limitation — it signals a filmmaker who designed to their means.
No cast member carries recognizable market value in any territory based on the materials supplied. For a first feature this is normal, but it removes the single most common lever for triggering an advance, and positioning must compensate elsewhere.
The poster commits to a restrained clinical palette and resists the over-saturated horror-title convention. It reads as considered. The title treatment sits slightly small against the negative space and would benefit from a scale pass before any market outing.
Marketed as psychological thriller, and the synopsis supports that — no mismatch between label and material, which is more than many submissions manage. The open question is whether the finished film leans far enough into horror mechanics to satisfy genre-platform acquisition teams.
Bio cites two short films with festival selections at regional European genre events, and a background in documentary camera work. This is a credible emerging-director profile: enough of a track record to be taken seriously by programmers, not enough to independently drive an acquisition.
Nothing in the submitted materials indicates an agent, manager, sales agent or distributor relationship. Recommendations below therefore assume direct self-submission and do not rely on an existing sales apparatus. If representation does exist and was simply not disclosed, several items below would change — flag it before acting on this.
Cast: Four-person cast, none with credits that register internationally on the materials provided. Treat cast as neutral in positioning: it neither helps nor actively hinders, but it cannot be the hook.
Programmers curating single-location and psychological horror sidebars are the most receptive first audience — this is exactly the profile those strands are built to surface.
The audience for contained supernatural-adjacent thrillers on dedicated horror platforms is well-defined and does not require star recognition to press play.
Programmes specifically framed around first features give the project a context where "debut" is the selling point rather than a caveat.
Tip: Do not lead pitch materials with cast. Lead with the premise line and the contained-production economics — that combination is what the relevant buyers are actually scanning for.
Tip: Every channel below will require a full screener before any decision. Have a subtitled, password-protected link ready before the first approach — a materials-only pitch to a platform acquisitions team will not progress.
Tip: A festival run is doing double duty here: it is both audience validation and the most realistic route to a sales agent noticing the project. Sequence accordingly — festivals first, platform outreach after there is a laurel to cite.
Tip: Some broadcast slots and festival feature categories set minimums at 80 or 90 minutes. Check each target's stated runtime rules before submitting; where 78 minutes disqualifies, the project is better routed to strands that explicitly programme short features.
There is no realistic minimum-guarantee or cash-advance market for this project as it currently stands, and it would be dishonest to imply otherwise. Advances in contained genre are driven almost entirely by cast recognition, an existing sales-agent relationship, or a major-festival premiere — this project has none of the three. Pursuing MG conversations now would consume months and produce passes that are recorded against the title. That position is not permanent: a strong premiere at a recognized genre festival is the specific event that would make this tier worth revisiting, and it is the reason the festival tier below is weighted more heavily than it would be for a project with cast attached.
This is where the project realistically earns. Contained genre features license well to platforms whose audience is defined by genre rather than by star, and flat licence fees at this tier are modest but real. Approach after there is at least one festival selection to cite.
The festival tier carries more strategic weight here than for a project with cast or representation, because it is the mechanism that unlocks the other two tiers. Target genre-specialist events with industry attendance rather than volume-submitting to general festivals.
Partly. A withheld antagonist is a standard device and on its own would not distinguish anything. What is less common is committing to it completely in a debut — no reveal, no creature, no compromise in the third act — and pairing it with a protagonist whose job is to go unnoticed. The premise is familiar; the discipline is the distinctive part, and that is what the marketing should claim rather than originality.
The successful examples in this bracket fix one rule in the first ten minutes and never break it, which lets an audience do the frightening work themselves. The rule is demonstrated rather than explained, usually by showing the consequence of breaking it to a minor character before the leads understand it.
The common failure is a third act that loses nerve and shows the source — usually because a financier or a test screening asked for it. What was a coherent formal idea becomes a low-budget monster reveal, and the film is then judged against films with ten times the effects budget.
Rights for North America, UK, Ireland, Australia and New Zealand. Financial terms were not disclosed publicly, and we will not estimate one. Negotiated via Cinetic on the filmmakers' side, which is itself the signal worth noting.
Why comparable: A feature debut from a writer-director whose prior credits were shorts, acquired ahead of a festival premiere. That is close to this project's profile. Where it diverges: it carried recognisable cast (Milly Shapiro, Shannyn Sossamon) and had a sales representative negotiating. Both are levers this project currently lacks, and both plausibly account for the deal happening at all.
Acquired ahead of Overlook Film Festival screenings. Terms not public. Began its festival run at FrightFest before the deal.
Why comparable: Closest comparison of the three: a debut feature acquired on the strength of a festival run rather than cast. This is the pattern this project would need to reproduce — and it shows the sequence matters, since the festival play preceded the acquisition rather than following it.
Terms not public. Premiered at Beyond Fest before acquisition.
Why comparable: Included to show the pattern rather than as a direct match — non-English-language J-horror with a different route in. Relevant only in confirming that Shudder's 2026 buying has run through festival premieres consistently.
Shudder is demonstrably active for this profile in 2026, but the shape of that activity matters more than the fact of it. Their recent acquisitions have come through festival premieres rather than direct submission, and reporting on their acquisition strategy is explicit that they are not writing the scale of minimum guarantee that a major streamer would deploy for a genre title. That is consistent with the Tier 1 assessment above: the money here is a licence fee, not an advance. Industry coverage places their thriller acquisition activity at roughly 43 tracked signals year-to-date, well behind Lionsgate and Apple, which is worth knowing before treating them as the obvious first call.
Four separate 2026 acquisitions traced through festival premieres — Tribeca, Overlook, FrightFest, Beyond Fest. Their team is reported to scout in person at FrightFest, Fantasia and Sitges rather than working from submissions.
For this project: Getting into one of those three festivals is worth more to this project than any amount of direct approach. It is the actual acquisition route, not a credential to cite afterwards.
Both substantially more active in thriller than Shudder by tracked signal volume in 2026. Neither reads cold submissions; both work rep-led or producer-driven.
For this project: Higher volume does not mean more accessible. For an unrepresented debut these are not realistic near-term targets, and time spent on them is time not spent on the festival route that is.
Trade commentary through 2025-26 notes indie companies increasingly favouring thrillers over pure horror for broader audience reach.
For this project: The psychological-thriller framing is the right one for this project commercially. Leaning harder into horror mechanics in the marketing would narrow the buyer pool rather than widen it.
One location, four actors, no effects budget — a night-shift cleaner becomes convinced a comatose patient is speaking to her through the ward intercom.
The horror does not appear. It speaks — through the hospital intercom, in a voice that should not be there.
A woman nobody listens to is the only one hearing something — set in the parts of a hospital the public never sees.
Everything above concerns selling this project in its current form. This section asks a different question: what else could it be? Ranked by what is realistically reachable from where you stand now.
The strongest asset here is not the film's sale value but the evidence it provides: a first-time director delivering a coherent, contained genre piece on almost no money, with legible visual control. That is a financing argument for the next project rather than a revenue argument for this one.
What it takes: No new money on this film. It reframes what the festival run is for — evidence gathering rather than a sale campaign — and requires a second script ready to show when the first conversations happen.
The premise is a mechanism rather than a closed story: a hospital where sound behaves wrongly on the night shift. That generates episodes without requiring the same characters, which is what an anthology needs and what a single-location feature usually cannot offer.
What it takes: Requires a series bible and at least one further script before anyone will engage. Realistically a year of unpaid development, and only worth starting if the feature earns attention first.
The film's subject — invisible night-shift labour inside a hospital, a worker nobody listens to — has a use beyond genre programming. That framing opens medical-humanities teaching, nursing education and healthcare-institution licensing, where completion date and cast recognition do not matter at all.
What it takes: Low cost, slow returns, small individual cheques. Requires reframing the marketing materials entirely — a horror one-sheet will not open this door — and access usually runs through an aggregator rather than direct.
This project holds its full premiere status and that is its single most valuable and most easily wasted asset. The 2026 submission windows for the major genre festivals have closed, which is a gift rather than a setback: it removes the temptation to enter something small now and forecloses nothing. The plan is to hold the premiere for the 2027 majors, keep the film entirely off the internet until then, and use the intervening months to fix the key art and confirm technical specs.
These are the festivals whose selection would materially change the project's market position, and all three are places genre acquisitions teams are reported to scout in person. Submit to all three in the same cycle rather than sequentially — they run at different times of year and a rejection from one does not prejudice another, whereas a premiere spent early rules out all of them.
FIAPF-accredited, the oldest and largest genre festival in the world, and the single strongest genre credential available to a debut. Programmes psychological and supernatural material well beyond explicit horror, which suits this film.
Strongest North American genre festival for launching low-budget and contained horror into distribution, with a documented record of titles being acquired directly out of the programme.
The UK genre festival with the most direct industry attendance, and non-competitive, which lowers the stakes of a selection while keeping the visibility.
These accept work that has already premiered, so they cost nothing in premiere status. They exist to extend a festival run rather than to start one — entering them first would be spending the asset on the cheapest available option.
The festival founder is stated to watch every submitted film personally, which for an unrepresented debut with no cast is a materially better proposition than a festival where a screener may never be opened.
A narrower field where a first feature is an advantage rather than a caveat, and where selections accumulate into a citable record for platform conversations later.
Budget. Sitges entry fees run roughly €60-90 per category, and only one category per film is permitted without paying again. Budget for three first-wave submissions at broadly that level, and treat that as the priority spend. Second-wave entries are cheaper individually but add up quickly; cap them rather than submitting broadly. Fee waivers exist for Sitges but only through partner promotion organisations and academic institutions in your own country — worth investigating early, since they cannot be requested from the festival directly.
Where not to submit. Do not enter any festival that does not require premiere status until the first wave has answered — that is the entire logic of this plan. Avoid pay-to-play operations that issue laurels without programming, which carry no weight with the buyers named in this report and are increasingly recognised as noise. And do not put the film, or any substantial excerpt, online in the meantime: FrightFest disqualifies films available online outright, and it is not the only one.
Deadlines and fees change between editions. Confirm every date on the festival's own site before paying an entry fee — this report states the edition each date refers to, but a calendar can shift after it was written.
Written for this project, addressed to a type of recipient rather than a named person. You supply the addressee. Observe the sending discipline on each — the channels above are finite, and a scattergun campaign burns them for you as much as for anyone.
Angle: Programmers are choosing a programme, not buying a product. Lead with the formal idea and be specific about what it would give an audience in a room.
One programmer per festival, never several at once. If there is no answer, one follow-up after their stated notification window and no more. Programmers talk to each other, and a duplicated approach is remembered.
Angle: This reader is doing arithmetic. Give them the numbers before the story, and be explicit about what you are asking for.
One approach per company. Do not send this in parallel with the festival approach to the same group — several genre companies run festivals as well, and receiving both looks like a mailing list.
Angle: Do not approach cold before a festival credential exists. When you do, lead with the audience fit and be blunt about what the film is not.
Hold this one until at least one festival selection can be cited — the platforms in this space have been acquiring out of festivals, and a cold approach without that credential spends the contact for nothing. One door per platform, maximum two follow-ups.
This Market Read is based on submitted materials alone — no LSN team member has manually verified these findings, and no live audience has seen The Quiet Hours (SAMPLE) yet. The natural next step is our Distribution Opinion: manual verification of everything above, named contacts with submission routes for each channel, and a written verdict from LSN's founder — a person putting their name to the judgement. What you paid for this report credits toward it within 30 days.
Reply to distribution@livescreeningsfilmfestival.com, or visit livescreeningsfilmfestival.com/distribution to discuss next steps.